Skip to search formSkip to main contentSkip to account menu

HZT-501

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2012
Review
2012
HZT-501 (DUEXIS®; ibuprofen 800 mg/famotidine 26.6 mg) gastrointestinal protection in the treatment of the signs and symptoms of rheumatoid arthritis and osteoarthritis
Arthritis affects nearly 50 million people in the USA and, with the aging of the population, the prevalence is expected to rise… 
Review
2012
Review
2012
DUEXIS® (ibuprofen 800 mg, famotidine 26.6 mg): a new approach to gastroprotection for patients with chronic pain and inflammation who require treatment with a nonsteroidal anti-inflammatory drug
Chronic pain conditions affect at least 116 million US adults and more than one-third of adults worldwide. Nonsteroidal anti… 
2011
2011
Reducing the incidence of peptic ulcers with ibuprofen-famotidine combined pill, HZT-501 (reduce): phase-III, double-blind multi-centre trials
Introduction The prevention of peptic ulcers induced by non-steroidal anti-inflammatory drugs (NSAIDs) is hampered by the high… 
2010
2010
HZT-501, a Novel Combination Tablet of Ibuprofen and Famotidine, Provides Pharmacokinetics Comparable to European Commercially Available Ibuprofen in a Patient-Friendly Dosing Form: Evaluation in…
HZT-501, a Novel Combination Tablet of Ibuprofen and Famotidine, Provides Pharmacokinetics Comparable to European Commercially… 
2010
2010
T1137 HZT-501, a Novel Combination Tablet of Ibuprofen and Famotidine, Provides Pharmacokinetics Comparable to Commercially Available Ibuprofen in a Patient-Friendly Dosing Form: Evaluation in…
Review
2009
Review
2009
407 Does High-Dose Famotidine Reduce Gastric and Duodenal Ulcers in NSAID Users? Two Double-Blind Six-Month Trials of Single-Tablet Combination Ibuprofen-Famotidine vs. Ibuprofen Alone (Reduce-1 and…
Review
2009
Review
2009
408 Increased Aspirin Use and Upper Gastrointestinal Bleeding Rates in Socially Deprived Patients
2009
2009
T1974 HZT-501, A Novel Combination of Ibuprofen (Ibu) and Famotidine (FAM), Provides Pharmacokinetics Comparable to That of Commercially Available Ibu and Fam in a Patient-Friendly Dosing Form…
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)